Legal Opinion
In Re Rezulin Products Liability Litigation
District Court, S.D. New York
Decided August 18, 2004No. MDL 1348. No. 00 Civ. 2843(LAK)PublishedCited by 4 opinions
1Opinion of the Court
MEMORANDUM OPINION
KAPLAN, District Judge.
Plaintiffs in these actions seek damages for personal injuries allegedly sustained as a result of their use of the prescription diabetes medication Rezulin. Although the complaints assert numerous claims, the defendants contend that all properly are construed as seeking recovery for failure to warn of Rezulin’s side effects. 1 Plaintiffs do not contest this characterization. 2
Defendants Warner-Lambert Co. and Pfizer, Inc., move for summary judgment dismissing the complaints on the grounds that there are no genuine issues of material fact with respect…
2Cases cited22 opinions
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Alm v. Aluminum Co. of AmericaTexas Supreme Court · 1986
- Virgin Atlantic Airways Limited v. British Airways PlcCourt of Appeals for the Second Circuit · 2001
- Martin v. HackerNew York Court of Appeals · 1993
- Magro v. Ragsdale Brothers, Inc.Texas Supreme Court · 1986
17 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Cochran v. Wyeth, Inc.Superior Court of Pennsylvania · 2010
- In Re Avandia Marketing, Sales Practices & Products Liability LitigationDistrict Court, E.D. Pennsylvania · 2011
- Brigman v. Wyeth, Inc.New Jersey Superior Court Appellate Division · 2005
- In Re Diet Drug LitigationNew Jersey Superior Court Appellate Division · 2005